Parallel Study definition

Parallel Study means the methodology for conducting individual interconnection studies where the utility studies multiple separate proposed projects on a feeder or substation at the same time (specifically they may be commenced in sequence, but they overlap and subsequent studies begin before studies of projects ahead in the queue are completed). Parallel study assumes for any given project that projects ahead of them in the queue will be completed but communicates which projects those are and what upgrades they entail.
View Source
Parallel Study means the methodology for conducting individual interconnection
View Source
Parallel Study means the methodology for conducting individual interconnection studies in which the utility studies multiple separate proposed projects on a feeder or substation at the same time (specifically they may be commenced in sequence, but they overlap and subsequent studies begin before studies of projects ahead in the queue are completed). Parallel study assumes for any given project that
View Source

More Definitions of Parallel Study

Parallel Study means the methodology for conducting individual interconnection studies where the utility studies multiple separate proposed projects on a feeder or substation at the same time (specifically they may be commenced in sequence, but they overlap and subsequent studies begin before
View Source

Related to Parallel Study

  • Phase III Trial means a Clinical Trial of an investigational product in subjects that incorporates accepted endpoints for confirmation of statistical significance of efficacy and safety with the aim to generate data and results that can be submitted to obtain Regulatory Approval as described in 21 C.F.R. 312.21(c), or a comparable Clinical Trial prescribed by the relevant Regulatory Authority in a country other than the United States.

  • Phase III Study means a human clinical trial that is prospectively designed to demonstrate statistically whether a product is safe and effective for use in humans in a manner sufficient to obtain regulatory approval to market such product in patients having the disease or condition being studied as described in 21 C.F.R. § 312.21(c) (FDCA), as amended from time to time, and the foreign equivalent thereof.

  • Phase III Clinical Study means a human clinical study of a product on a sufficient number of subjects that is designed to establish that such product is safe and efficacious for its intended use, and to determine warnings, precautions, and adverse reactions that are associated with such product in the dosage range to be prescribed, which trial is intended to support Regulatory Approval of such product, as described in 21 C.F.R. 312.21(c). 1.185. [***] 1.186. [***]

  • Phase II Trial means a clinical trial of a Licensed Product, designated as a Phase II Trial and the principal purpose of which is to make a preliminary determination that such Licensed Product is safe and active in a patient population for its intended use and is designed to obtain sufficient information about such Licensed Product’s efficacy to permit the design of a Phase III Trial(s), and generally consistent with 21 CFR § 312.21(b). For purposes of this definition, Phase II trial shall specifically exclude expansion cohorts from Phase I Trial(s).

  • Phase III Clinical Trial means a human clinical trial of a product, the design of which is acknowledged by the FDA to be sufficient for such clinical trial to satisfy the requirements of 21 C.F.R. 312.21(c) (as amended or any replacement thereof), or a similar human clinical trial prescribed by the Regulatory Authority in a country other than the United States, the design of which is acknowledged by such Regulatory Authority to be sufficient for such clinical trial to satisfy the requirements of a pivotal efficacy and safety clinical trial.